Objectives: Cardiac arrest is associated with morbidity and mortality because of cerebral ischemia. Therefore, we tested the hypothesis that higher regional cerebral oxygenation during resuscitation is associated with improved return of spontaneous circulation, survival, and neurologic outcomes at hospital discharge. We further examined the validity of regional cerebral oxygenation as a test to predict these outcomes. Design: Multicenter prospective study of in-hospital cardiac arrest. Setting: Five medical centers in the United States and the United Kingdom.
Patients: Inclusion criteria are as follows: in-hospital cardiac arrest, age 18 years old or older, and prolonged cardiopulmonary resuscitation greater than or equal to 5 minutes. Patients were recruited consecutively during working hours between August 2011 and September 2014. Survival with a favorable neurologic outcome was defined as a cerebral performance category 1-2. Interventions: Cerebral oximetry monitoring. Measurements and Main Results: Among 504 in-hospital cardiac arrest events, 183 (36%) met inclusion criteria. Overall, 62 of 183 (33.9%) achieved return of spontaneous circulation, whereas 13 of 183 (7.1%) achieved cerebral performance category 1-2 at discharge. Higher mean ± sd regional cerebral oxygenation was associated with return of spontaneous circulation versus no return of spontaneous circulation (51.8% ± 11.2% vs 40.9% ± 12.3%) and cerebral performance category 1-2 versus cerebral performance category 3-5 (56.1% ± 10.0% vs 43.8% ± 12.8%) (both p < 0.001). Mean regional cerebral oxygenation during the last 5 minutes of cardiopulmonary resuscitation best predicted the return of spontaneous circulation (area under the curve, 0.76; 95% CI, 0.69-0.83); regional cerebral oxygenation greater than or equal to 25% provided 100% sensitivity (95% CI, 94-100) and 100% negative predictive value (95% CI, 79-100); regional cerebral oxygenation greater than or equal to 65% provided 99% specificity (95% CI, 95-100) and 93% positive predictive value (95% CI, 66-100) for return of spontaneous circulation. Time with regional cerebral oxygenation greater than 50% during cardiopulmonary resuscitation best predicted cerebral performance category 1-2 (area under the curve, 0.79; 95% CI, 0.70-0.88). Specifically, greater than or equal to 60% cardiopulmonary resuscitation time with regional cerebral oxygenation greater than 50% provided 77% sensitivity (95% CI,:46-95), 72% specificity (95% CI, 65-79), and 98% negative predictive value (95% CI, 93-100) for cerebral performance category 1-2. Conclusions: Cerebral oximetry allows real-time, noninvasive cerebral oxygenation monitoring during cardiopulmonary resuscitation. Higher cerebral oxygenation during cardiopulmonary resuscitation is associated with return of spontaneous circulation and neurologically favorable survival to hospital discharge. Achieving higher regional cerebral oxygenation during resuscitation may optimize the chances of cardiac arrest favorable outcomes. (Crit Care Med 2016; 44:1663-1674) Key Words: cardiac arrest; cardiopulmonary resuscitation; cerebral oximetry; near-infrared spectroscopy; resuscitation I schemic brain injury following cardiac arrest (CA) is a major health burden. Among CA survivors, neurologic, cognitive, and functional deficits are common, with only 3-7% recovering to their prior functional status (1) (2) (3) (4) . Cerebral ischemia contributes to morbidity and mortality through a two-step process; ischemia during CA is followed by reperfusion injury after return of spontaneous circulation (ROSC), culminating in organ failure and death in the hours/ days after cardiopulmonary resuscitation (CPR) (5-7). As the magnitude of reperfusion injury is determined by the magnitude of ischemia during CA (5-7), the ability to detect, quantify, and ameliorate cerebral ischemia in real-time during CA is of vital clinical importance. Nevertheless, one of the main hurdles to improving CA outcomes to date has been the lack of a real-time detection system capable of identifying cerebral ischemia and the quality of oxygen delivery during CPR.
Cerebral oximetry using near-infrared spectroscopy (NIRS) is a noninvasive monitoring system that transmits and detects near-infrared light through forehead sensors and continually measures regional cerebral oxygen saturation (rSo 2 ) in the frontal lobe of the brain (8) . It determines the ratio of oxyhemoglobin/deoxyhemoglobin, and it provides a measure of rSo 2 with normal values close to venous saturation (70%) (8) . NIRS does not rely on pulsatile flow, enabling it to be used during CA (8) . Although validated and used in many settings (8) (9) (10) , few studies have examined its use during CA (11) (12) (13) (14) (15) (16) . Although a number of small studies have indicated that ROSC is associated with higher rSo 2 during CPR in out-of-hospital CA (OHCA) and in-hospital CA (IHCA) (11) (12) (13) (14) (15) (16) , they lacked the power to determine the accuracy and clinical utility of rSo 2 as a predictor of ROSC. Recently, a single rSo 2 measured on arrival to the emergency department was found to predict survival with favorable neurologic outcomes at 90 days after OHCA (17, 18) . However, a single rSo 2 is unlikely to reflect the overall balance between cerebral ischemia and oxygen delivery throughout CPR. Furthermore, as OHCA comprises a largely different population to IHCA, the applicability of these findings to IHCA remains unknown. Consequently, the optimal level of cerebral oxygen delivery during CPR, as well as the optimal read-out measure that is associated with ROSC and survival with favorable neurologic outcomes following CA, remains unknown.
Therefore, we conducted a prospective multicenter study to test the hypothesis that sustained ROSC and survival with favorable neurologic outcomes at hospital discharge after IHCA are associated with higher cerebral oxygenation/delivery during CPR. The
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primary objective was to examine the relationship between rSo 2 and sustained ROSC. The secondary objective was to determine the relationship between rSo 2 and survival with favorable neurologic outcomes at hospital discharge, as well as the accuracy, clinical utility, and optimal rSo 2 measure to predict sustained ROSC, survival, and neurologic outcomes at hospital discharge.
MATERIALS AND METHODS

Study Population and Enrollment
We studied IHCA patients in five hospitals across the United States (Stony Brook University Medical Center, Stony Brook) and United Kingdom (Southampton University Hospital, Southampton, Hammersmith Hospital, London; Queen Alexandra Hospital, Portsmouth and Heart of England National Health Service Foundation Trust, Birmingham). All study data were sent to a data coordinating center at Stony Brook University. Participants were enrolled between August 2011 and September 2014. Patients who met inclusion and exclusion criteria were recruited consecutively during working hours (mostly 08:00-17:00 weekdays). Inclusion criteria were IHCA, age 18 years old or older, and CPR lasting greater than or equal to 5 minutes. Exclusion criterion was OHCA. We chose CA greater than or equal to 5 minutes as short CA is not associated with the same adverse outcomes as CA lasting greater than or equal to 5 minutes (19) . The research protocol received ethics committee approval prior to enrolling the first participant. Written informed consent was obtained from all CA survivors; a waiver of consent was approved to use data for nonsurvivors. Patients who survived the initial CA were followed up until hospital discharge or death.
Study Definitions and Outcome Measures
CA was defined as absent heartbeat and respirations requiring CPR. Initial ROSC was defined as the presence of a palpable pulse elicited after interruption of CPR. Sustained ROSC was defined as ROSC lasting greater than or equal to 20 minutes (for the purpose of our calculations, only rSo 2 values up to the point of initial ROSC were used as rSo 2 values during the 20-min period after initial ROSC reflect cardiac contractility rather than CPR itself). Survival with a favorable neurologic outcome was defined as a cerebral performance category (CPC) 1-2. Unfavorable outcomes were defined as CPC 3-5. The five CPC categories are 1) good cerebral performance (normal life with possible minor psychologic and/or neurologic deficits), 2) moderate cerebral disability (independent activities of daily life), 3) severe cerebral disability (neurologic damage and dependence on others but preserved consciousness), 4) coma or vegetative state, and 5) death (20) .
Patient Characteristics
Data corresponding to potential confounders and effect modifiers for initial and sustained ROSC or survival and neurologic outcomes to hospital discharge were collected. Demographic data were collected, including patient gender, age, ethnicity, severity of critical illness score using the Acute Physiology and Chronic Health Evaluation II scoring system, and chronic disease burden using the Charlson comorbidity index (a scale from 0 to 33, with higher scores indicating greater burden of coexisting conditions) (21) . We further examined variables that could impact oxygenation: hemoglobin, Pao 2 (pulse oximetry and hence peripheral oxygen saturation measurements were not feasible as pulse oximetry relies on pulsatile flow, which is typically absent during CA. We, thus, used Pao 2 as an indirect marker of the quality of peripheral oxygenation based on the known relationship between Pao 2 and oxygen saturation of hemoglobin according to the oxygen dissociation curve), CPR-related factors (initial rhythm, CPR duration, and hospital site), and postresuscitation factors (hypothermia, mean arterial pressure, glucose, Pao 2 , and Paco 2 ) (5) in patients who survived beyond sustained ROSC.
Use of Cerebral Oximetry
Patients received CPR in accordance with advanced cardiac life support (ACLS) recommendations (2010) (22) . Dedicated research staff at participating sites were provided with a pager and attended all CA events announced through the pager and established cerebral oximetry monitoring. Each clinical site was provided with the same oximetry equipment to minimize measurement errors (Equanox 7600, Nonin Medical, Plymouth, MN). This equipment is capable of measuring cerebral oxygenation during low-flow states with an rSo 2 range between 0% and 100%. An adhesive sensor with two nearinfrared light sources and detectors was placed on the forehead of each CA patient for cerebral oximetry monitoring. A single sensor on either side of the forehead was considered sufficient to measure rSo 2 because cerebral perfusion during CA is predominantly dependent on the quality of the circulation. This was determined during a prepilot study where rSo 2 values were compared on both sides of the forehead during CA and found to be equal. Prior to data collection, the research staff was certified in the collection of cerebral oximetry data, the completion of study case report forms, and data entry into Research Electronic Data Capture (REDCap), a web-based data entry system prior to study commencement. Study protocols were reinforced during monthly teleconference meetings conducted for the length of data collection. All rSo 2 data were recorded and automatically stored on the equipment without the need for further input from research staff, thus minimizing operator bias errors. Staff marked the time of initial ROSC, sustained ROSC, or the end of CPR using dedicated event-marking buttons on the oximeter. Data were downloaded onto a designated study computer and transmitted to the data coordinating center using REDCap. All rSo 2 data were managed at Stony Brook University by a dedicated data coordinator. Two dedicated statisticians (blinded to the patients' histories) analyzed all rSo 2 data. In order to minimize the instrument bias, the oximeters were calibrated according to the manufacturer's instructions.
Statistical Analysis
Fisher exact and chi-square tests with exact p values using Monte Carlo simulation were used for categorical variables. Student t tests or Wilcoxon signed rank tests were used to compare continuous variables. One-way analysis of variance was used to compare rSo 2 during CPR in patients without ROSC, those with ROSC who subsequently died, and those with ROSC who survived with CPC 1-2. A log-binomial regression and a multivariable log-binomial regression model was used to estimate relative risks (RRs) of ROSC after adjusting for possible confounders. Logistic regression models and receiver operating characteristic curves were used to evaluate the rSo 2 's classification performance for predicting ROSC and CPC 1-2. Using the clinical determination of ROSC (22) and the CPC scoring system at hospital discharge as standards, we compared the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the curve (AUC) of six predetermined rSo 2 variables. Three of these variables related to cerebral oxygenation throughout CPR (mean rSo 2 , median rSo 2 , percentage time with rSo 2 > 50% during CPR). The other variables are related to the last 5 minutes of CPR as they are related to initial ROSC or termination of CPR: mean, median, and percentage of time with rSo 2 greater than 50%. Five minutes was chosen to assess the state of cerebral oxygenation during the last two cycles of CPR for every documented case of ROSC. The percentage of time with rSo 2 greater than 50% was chosen based on our prior experience (13) (14) (15) (16) . Although using sustained manual or mechanical CPR may raise rSo 2 up to 50-55%, achieving levels of greater than 60% even with sustained high quality CPR in accordance with current ACLS standards is often not feasible. Therefore, we chose an rSo 2 target with generalizable applicability. The accuracy of each test was summarized by AUC values and their 95% CIs. Sensitivity, specificity, PPV, and NPV with their 95% CIs were reported for a series of preselected cutoff values rising in 5% increments from rSo 2 (25-65%) for each rSo 2 variable except for percentage of time with rSo 2 greater than 50% (reported as %time) to further describe the classification performance of rSo 2 .
Statistical significance was set at 0.05, and analyses were conducted using SAS 9.3 (SAS Institute, Cary, NC).
RESULTS
Demographics and Clinical Characteristics
There were 504 IHCA events; among which, 183 patients (36.3%) met inclusion criteria. The mean age was 68.6 years (sd = 15.0); 60.7% were men; and 80.9% were white. Pulseless electric activity (PEA) was the most common presenting rhythm (66.7%). The patients' demographic and clinical characteristic data are summarized in Tables 1 and 2 . Research staff typically arrived at the site of CA after 6-8 minutes of CA onset (Table 1 ). 
ROSC, Survival, and Neurologic Outcomes
Overall, 62 of 183 patients (33.9%) achieved sustained ROSC, whereas 13 of 183 (7.1%) survived with CPC 1-2. Among the CPC 3-5 patients, 4 of 170 (2.4%) had CPC 3; none CPC had 4, and 166 of 170 (97.6%) had CPC 5. Of 166 CPC 5 patients, 121 (72.9%) were declared dead after unsuccessful CPR (no ROSC), whereas 45 (27.1%) initially survived CPR but died prior to hospital discharge (Fig. 1) . Among this group of 45 patients, 30 (66.7%) died less than or equal to 1 day after ROSC; the remaining 15 (33.3%) died in hospital between 2 and 57 days after ROSC.
Patients with sustained ROSC had higher rSo 2 during CPR ( Fig. 2A) . The mean ± sd of rSo 2 (mean per patient) during CPR was 51.8% ± 11.2% versus 40.9% ± 12.3% (p < 0.0001).
All six tested rSo 2 variables were higher in those with ROSC (all p < 0.001) ( Table 3) .
Patients with CPC 1-2 had a higher mean rSo 2 during CPR versus CPC 3-5 patients (Fig. 2B) . The mean ± sd rSo 2 (mean/patient) during CPR was 56.1% ± 10.0% versus 43.8% ± 12.8% (p < 0.001). Significant differences were noted in all six measured rSo 2 variables (p < 0.01 for all) ( Table 4) .
A stepwise increase in mean rSo 2 was noted in patients with no ROSC (40.9% ± 12.3%) versus those who died in hospital after sustained ROSC (50.6% ± 11.8%) versus those who survived with CPC 1-2 at discharge (56.1% ± 10.0%) (p < 0.001) (we did not analyze the four patients with CPC3 because of the low numbers). Patients with CPC 1-2 had a nonsignificant 5.5% higher mean rSo 2 (95% CI, 3.4-14.3) than those who died after sustained ROSC. In turn, this group had a 9.7% higher mean rSo 2 during resuscitation (95% CI, 4.8-14.6) than those who died without achieving ROSC (p < 0.001) (Fig. 3) .
Clinical Utility of rSo 2 as a Test to Determine ROSC
The prediction accuracy of all six rSo 2 variables (mean rSo 2 , median rSo 2 , percentage of time with rSo 2 > 50% during CPR, mean, median, and percentage of time with rSo 2 > 50% in the last 5 min of CPR) provided similar results for ROSC ( Table 5 ). The variable with the highest AUC was mean rSo 2 during the last 5 minutes of CPR (AUC, 0.76; 95% CI, 0.69-0.83) ( Table 5) . For every 5% increase in mean rSo 2 in the last 5 minutes of CPR, there was 18% higher probability of achieving ROSC (RR, 1.18 with 95% CI, 1.13-1.23; p < 0.001) ( Table 6 ). After adjusting for CPR duration, every 5% increase in mean rSo 2 in the last 5 minutes of CPR was associated with 7% higher probability of achieving ROSC (RR, 1.07 with 95% CI, 1.03-1.12; p < 0.001) ( Table 6 ). The sensitivity, specificity, PPV, and NPV and for each of the preselected cutoff values of mean rSo 2 in the last 5 minutes of CPR are summarized ( Table 7 ). An rSo 2 greater than or equal to 25% provided 100% sensitivity (95% CI, 94-100) and Median (minimum, maximum) 67.11 (0.00, 100.00) 0.00 (0.00, 100.00) CPC = cerebral performance category, rSo 2 = regional cerebral oxygen saturation. 100% NPV (95% CI, 79-100), whereas an rSo 2 greater than or equal to 65% provided 99% specificity (95% CI, 95-100) and 93% PPV (95% CI, 66-100) for the prediction of ROSC.
Clinical Utility of rSo 2 to Determine Survival With Favorable Neurologic Outcomes at Hospital Discharge
The rSo 2 variable with the highest AUC value to predict CPC 1-2 was %time with rSo 2 greater than 50% throughout CPR (AUC, 0.79 with 95% CI, 0.70-0.88) ( Table 8) . Every 5% increase in %time with rSo 2 greater than 50% provided 15% higher probability of achieving CPC 1-2 (RR, 1.15 with 95% CI, 1.06-1.26; p = 0.002) ( Table 9 ). The sensitivity, specificity, PPV, and NPV for %time with rSo 2 greater than 50% during CPR are summarized (Table 10 ). Spending more than 24% time during CPR with rSo 2 greater than 50% provided 100% sensitivity (95% CI, 75-100), 55% specificity (95% CI, 47-62), 14% PPV (95% CI, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] , and 100% NPV(95% CI, 96-100) for CPC 1-2. On the other hand, spending more than 60% CPR time with rSo 2 greater than 50% provided 77% sensitivity (95% CI, 46-95), 72% specificity (95% CI, 65-79), 18% PPV (95% CI, 9-30), and 98% NPV (95% CI, 93-100) for predicting CPC 1-2.
Repeated Analysis of the rSo 2 Data to Examine for Potential Cases of CA With Unrecognized Underlying Cardiac Output
Patients in CA with PEA may include two distinct populations: 1) those with a true no cardiac output state (cardiac standstill) and 2) those with a very low cardiac output state (severely weakened cardiac contractions without a palpable pulse). From a practical perspective, only real-time echocardiography during CA can distinguish between these two states; yet, this is not routinely feasible or available during CA. Nonetheless, patients in the latter group may be expected to have higher rSo 2 levels after starting CPR on a background of a very low cardiac output compared with those with true cardiac standstill. Thus, we further compared rSo 2 levels in patients known to have cardiac standstill (asystole and ventricular fibrillation) with those in PEA. No significant difference in rSo 2 was observed between the PEA and the asystole/VF groups (mean ± sd rSo 2 , 45 ± 12.9 vs 42 ± 13, respectively), suggesting that the observed differences in rSo 2 during CPR in our study largely reflected the effect of CPR on oxygen delivery rather than the presence or the absence of cardiac contractility. Furthermore, as cardiac contractility typically leads to a steep rise in rSo 2 (25) , the observed gradual rise in rSo 2 in the final 5 minutes of CPR in patients with ROSC ( Fig. 2) did not seem consistent with the impact of a sudden resumption of cardiac contractility. Nonetheless, we reexamined the relationship between rSo 2 , sustained ROSC, and CPC 1-2 outcomes after omitting the last 2 minutes of rSo 2 data to account for the possibility that cardiac contractility may have preceded the clinical detection of ROSC between 2-minute CPR cycles. This revealed similar results for all six rSo 2 variables for ROSC (all p < 0.001) and CPC 1-2 outcomes (all p < 0.005). The AUC for the prediction of ROSC using rSo 2 in the final 5 minutes CPR changed to 0.72 (95% CI, 0.64-0.7976) and for CPC 1-2 outcomes using rSo 2 greater than 50% changed to 0.76 (95% CI, 0.64-0.87).
DISCUSSION
Our results indicate that ROSC and neurologically favorable survival following IHCA are associated with cerebral oxygenation and that cerebral oximetry can be used to assess the quality of cerebral oxygenation during CA. The main strength of this study is that rSo 2 data were collected throughout CPR for the purpose of studying the association between cerebral oxygenation with ROSC (11-16) and survival with favorable neurologic outcomes (17, 18) . The clinical utility of this study lies in identifying a real-time, noninvasive method to quantify cerebral oxygen delivery.
Although the overall period of time during CPR with rSo 2 greater than 50% best predicted survival with favorable neurologic outcomes, peak rSo 2 best predicted ROSC. Thus, higher cerebral oxygenation maintained throughout CPR may effectively attenuate cerebral ischemic and subsequent reperfusion injury, whereas a high peak rSo 2 may facilitate ROSC. Progressive increases in coronary perfusion pressure (CPP) from 15 to 60 mm Hg have been shown to lead to an increased likelihood of ROSC (23) , whereas CPP less than 15 mm Hg or an end-tidal Co 2 less than 10 mm Hg is largely incompatible with ROSC (23, 24) . Although these observations mirror our findings, the advantage of rSo 2 is that it also reflects the quality of cerebral oxygenation, a key factor in determining neurologic outcomes. Another practical advantage of rSo 2 is that it is noninvasive.
Although our results suggest that a low rSo 2 during CPR may predict poor outcomes, care should be exercised in interpreting these data. Cerebral oxygenation as measured by NIRS is a dynamic not a static measure, and therefore, a low rSo 2 may suggest a poor outcome where interventions aimed at improving cerebral perfusion have not been made or have been ineffective. If, despite all interventions, rSo 2 remains less than 25%, then a poor outcome may be inevitable. However, there is potential to improve rSo 2 during CPR (15, 24) .
Our study had limitations. Most nightime/weekend IHCA events were not included, limiting the generalizability of our findings. It remains unclear whether higher rSo 2 is a marker of less severity of critical illness or is an independent factor in CA outcomes. We had a reasonable sample; however, the low numbers of CPC 1-2 survivors (likely reflecting the impact of prolonged CA) (25) limited our ability to examine whether rSo 2 is an independent predictor for CPC 1-2 outcomes. Larger studies are needed to explore the utility of monitoring rSo 2 to predict survival with favorable neurologic outcomes in all IHCA cases, as well as other CA populations.
CONCLUSIONS
Cerebral oximetry is a real-time, noninvasive monitor for use during CPR. Increasing rSo 2 to greater than or equal to 65% favors ROSC, whereas rSo 2 less than 25% strongly favors the inability to achieve ROSC/survival or CPC 1-2. Higher rSo 2 during CPR may optimize the chances of achieving survival with favorable neurologic outcomes.
